.png)
Abstracts must be submitted by Monday, 25 August 2025, 23:59 hours (Singapore Standard Time, +8.00UTC). Strictly no extension will be granted.
These reports present completed original research on pharmacologic agents, therapeutic issues, and innovative services or outcomes of services provided to the patients with MS or related diseases.
These posters represent currently ongoing, uncompleted studies. The author may discuss preliminary results of the studies, provided the research methods have been validated. Topics may include clinical drug studies, therapeutics issues, innovative services, and outcomes.
These posters present a description of the evidence-based management and treatment of a patient from the author’s clinical practice with an uncommon presentation and/or clinically challenging scenario, emphasizing steps taken to maximize the likelihood of an optimal outcome.
These posters represent findings that have been presented at other meetings but contain information of interest to clinicians who care for patients with MS or related diseases. These completed studies need to be original research on pharmacologic issues, therapeutic considerations, innovative services, or outcomes related to MS and related diseases.
Submission via this portal only. Please fill all required fields, including age category (for award purpose), year of graduation and position in the organisation of the first presenting author. Only the first presenting author is required to submit a short biography. The rest are optional.
Submission of an abstract does not constitute registration for the congress. Presenters are required to register for the congress separately. Registration is compulsory for the publication of the abstracts. Those whose abstracts are accepted but did not register or turn up for the congress will not be published and may be banned from future abstract submissions.
Authors of accepted abstracts will be informed by early September. Please check your spam mails and use emails where you can be reached. Note that some organisations may have mail filters that may prevent our emails from reaching you.
Accepted presenting Authors MUST register for the congress. Further information regarding the size of the printed poster will be provided later.
By submitting your abstract, you (and all the authors involved) agree to have it possibly edited, included and published on the PACTRIMS website and in the Multiple Sclerosis Journal; and release the PACTRIMS Committees and Secretariat team from all responsibility for the continued accuracy of the information and any withholding copyright issue of the data or information contained within.
The best posters will be selected for the following special awards:
In an effort to forge a diversified MS community within the Asia Pacific Region, the PACTRIMS Travel Grant contributes funds to qualifying individuals’ travel expenses for Congress participation. This is done to encourage participation from healthcare professionals in the Asia Pacific Region, increasing the prominence and importance of research and interest in Multiple Sclerosis (MS) in the Region and encourage mutually beneficial interaction among MS healthcare professionals.
A limited number of 25 travel grants each USD1,000, will be made available to young scientists aged 35 or younger (born on or after 1 January 1990) and whose abstracts have been accepted for oral or poster presentations.
Eligibility
a. Travel grants are only eligible for onsite participants. Selected awardees will receive travel support and/or free registration to the congress. The travel grant amount will be transferred to the presenting author’s bank account after the congress.
b. Participants from low and low middle income countries qualify for travel grants. (Source: World Bank 2023 https://data.worldbank.org/). Please also refer to the list below. Citizens of Iran, Syria, Crimea, North Korea and Cuba are not eligible for the Travel Grant. Candidate residents in the host country (Japan) are not eligible for the grant.
c. Be practicing Healthcare Professionals in neurology and < 35 years of age including the following: Specialists/Physicians, Post-Graduate Students/Training Neurologists, Registrars, Medical Officers, Pharmacists, Nurses
d. Have an abstract accepted at the 17th PACTRIMS Congress, 2025.
Instructions for submission
Qualifying individuals must fill out an APPLICATION FORM; download ONLINE or from the registration desk during the Congress from 13-15 November 2024.
The following items are important and compulsory in your submission:
a. A photocopy of your passport front page showing your name and nationality.
b. A declaration from the candidate, written on the official stationery of the department confirming current status of employment, that is additionally counter signed by the Head of Department.
c. The application form (inclusive of bank account information, and all required fields on the form) must be filled in accurately. Failure to do so could inadvertently result in cancellation of travel funds. The application form is available online for download.
d. Completed applications and accompanying documents must be received by the Secretariat on or before the last day of the Congress, 15 November 2025 by 10.00am Japan local time. Late submissions will not be entertained and please adhere strictly to this deadline.
Payment
a. The grant will be credited to qualifying individuals via telegraphic transfer within 45 days after the end of the PACTRIMS Congress. Please provide complete and accurate bank details or PACTRIMS will deduct bank charges of USD$50 for every unsuccessful attempt.
b. Please note that after 2 unsuccessful attempts, PACTRIMS will cancel the travel grant.
Submission Deadline
Completed applications and accompanying documents must be received by the Secretariat on or before the last day of the Congress, 15 November 2025 by 10.00am Japan local time. Late submissions will not be entertained and please adhere strictly to this deadline.
LOW-INCOME ECONOMIES
LOWER-MIDDLE INCOME ECONOMIES